(adsbygoogle = window.adsbygoogle || []).push({ google_ad_client: "ca-pub-8679583308408160", enable_page_level_ads: true });

Saturday, May 26, 2018

Sunningdale

NAV of $1.98.
Dividend of 7.5 cents
Yield of 5.63%
Current price $1.33
Estimate EPS of 13.3 cents
PE is about 10x

Chart wise, it seems to have hit the bottom at around $1.26 level and manage to bounce-off and rises higher to $1.33.



The current price has managed to reclaimed and rises above it's 20 days moving average ,this is rather positive.



Short term wise, it may likely retest 1.36. Breaking out with ease + good volume that may drive the price higher towards 1.40 then 1.45 with extension to 1.58 level.
Chiong ah!

Not a call to buy or sell.

Trade/invest base on your own decision.



Sunningdale Tech - I have looked through Sunningdale Tech and here are my thoughts on this tech company.


Sunningdale Tech is a leading Asian tooling, plastic injection moulding and precision assembly company. They are currently operating in four main business segments namely automotive, consumer/IT/environment, healthcare and tooling/mould fabrication. They currently have 19 manufacturing facilities spread across 9 countries and as their chairman mentioned, they continue to receive queries from both new and existing customers who recognise their ability to undertake projects on a global scale. So far so good, the background business profile seems to suggest they are a global player in their field.



The chairman in the FY16 annual report did raised a few challenges their businesses constantly face such as foreign exchange movements, rising labour cost, pricing pressure from customers, rising input costs, and structural reforms in China (which affects their China based businesses).

With these backdrop, let us look into their business performance so far over the past decade. First, we look into how their revenues have grown over the past decade. Revenues have grown by a compounded annual growth rate (CAGR) of 6.52% over past decade.

Next, their operating profit has grown by a CAGR of 9.2% over the past decade.
Next, their profit attributable to shareholders has grown by a CAGR of 9.98% over the past decade.
Next, their diluted earnings per share (EPS) has grown by an impressive CAGR of 25.9% over the past decade.

This is a low profit margin company. Let's look at how the profit margins have changed a decade ago compared to now.
Operating profit margin = 4.6% (2007) vs 5.9% (2017)
Profit attributable to shareholders margin = 3.1% (2007) vs 4.3% (2017)





The various profit margins have improved over the past decade though they are generally still at low single digits. The operating profit, profit attributable to shareholders and diluted EPS have all grown faster than revenues. It seems that Sunningdale Tech have managed to keep the various operating expenses well controlled to achieve better operating efficiency. Indeed, the % of operating expenses (excluding finance cost) over revenues have decreased from 12.4% to 9.6% over the past decade. In 2017, operating expenses (excluding finance cost) only made up 9.6% of their revenue. They have been definitely doing well to reduce operating expenses while improving profit margins amidst a challenging business environment they operate in with pricing pressure from customers and rising input cost and labour cost over the past decade.

Now let's look some of the various metrics from their balance sheet and see how have they changed over the past decade.
Current ratio = 1.21 (2007) vs 1.74 (2017)
Quick ratio = 0.39 (2007) vs 0.39 (2017)
Debt to equity ratio = 0.29 (2007) vs 0.28 (2017)
Shareholder equity CAGR = 1.12%


This was a net net company (current assets > total liabilities) a decade ago and a decade later, it still maintains it's net net company status. The company has maintained similar leverage level taken a decade ago and now. It's balance sheet is strong as it has maintained it's net net status over the past decade. However, Sunningdale Tech did not grow it's shareholder equity at high CAGR thus not making their shareholders wealthier at a fast rate.

The returns on assets, returns on equity and returns on invested capital a decade ago were at low single digits of 2.36%, 3.75% and 3.62% respectively. However, the various returns have improved over the past decade and now returns on assets, returns on equity and returns on invested capital stand at 6.98%, 13.28% and 10.75% respectively. Clearly, the management has become more efficient over the past decade in producing better returns.

 The question now is can the management continue to improve their various returns any further or are these the best they can achieve? This is because the various returns though have improved over the past decade, have also remained stagnant around current levels for the past 3 years.
Next, we look at how their cashflows have grown. Operating cashflows have not grown much at all and remained at about similar levels now as compared to a decade ago. Free cashflows have decreased in their reported FY17 financial results as compared to a decade ago. I noticed the trend of their operating cashflows and free cashflows over the past decade can be quite volatile with some years having more operating cashflows and free cashflows while other years having lesser.

Nevertheless, their free cashflows are still able to meet their dividends paid. One may need to watch their future cashflows carefully to make sure their cashflows can continue to grow even while over any single year, it may show volatile swings. If future cashflows do not grow anymore and even show a decreasing trend, then it could be a potential red flag to watch out for.

Nevertheless, Sunningdale Tech has strong balance sheet. But, we will also like to see that it can continue to receive increasing operating and free cashflows from it's businesses as it continues it's growth. Or else, the current assets carried on their balance sheet though looking impressive giving them a net net status and especially made up of a good amount of trade and other receivables, may start to make one worry whether there are any difficulties with collecting cash from these receivables.


Overall, I find Sunningdale Tech still an alright investment for consideration. But based on some of the above potential weak spots such as the weakness of it's cashflows being raised and operating in a constantly challenging environment, I will put it as an alright but not fantastic investment idea.

Valuation wise, if we assume the diluted EPS will continue to grow at a historical CAGR of 25.9% for next 7 years, the fair share price is $9.84. Wait a minute! This is insane! Sunningdale Tech is only trading at $2 now. At $2 now, the market is according a forward CAGR of 1.9% for the diluted EPS of Sunningdale Tech. Either the market is very intelligent or very stupid from what I can see. Perhaps from certain potential weak spots in the businesses such as the volatile cashflows and challenging operating environment as mentioned earlier, the market is discounting Sunningdale Tech.

I also noticed that the diluted EPS of Sunningdale was also volatile as well over the past decade with some years swinging into losses. The significant growth in the diluted EPS came in only from 2015 to 2017. Previous years had much lower diluted EPS registered. Thus, I think it is better to watch out whether Sunningdale Tech can continue to register stable growth in it's diluted EPS. As such, I think I will perhaps follow the market's assumption that Sunningdale Tech will grow it's diluted EPS at CAGR of 1.9% as a conservative measure and see the current traded price of $2 as my final conclusion of it's fair share price. Any upside will have to depend on how Sunningdale Tech can stably grow it's diluted EPS and cashflows over the next 7 years.

Thus, a fair share price of $2 is not too low an estimate (factoring in a margin of safety for the investor) in order to give the company time in future to see whether they can stabilise their growth going forward in these two areas of their diluted EPS and cashflows, minimising their volatilities, and even avoid any potential losses. If they can do that, their share price will certainly have much room to run higher.

Not a call to buy or sell.
dyodd.



Friday, May 25, 2018

YZJ

YZJ - it has experienced another flushing down last Friday from $1.08 to close 10 cents lower at 98 cents.

This selling down come with super high volume that may suggest Bear is in total control.

It has broken down the support at $1.00, looks rather bearish!

From the weekly chart patterns, looks like it may go further down to revisit 90 cents then 80 cents with extension to 73.5 cents.

Not a call to buy or sell.
Pls dyodd.

17 May 2018: YZJ - After hitting the high of $1.66 on 19 Jan 2018, it has since corrected sharply and continue to go lower.



It has gone down to touch 1.10 on 4 April whereby a rebound has been triggered and rises higher to $1.26 on 20 April.



It has again failed to hold up above $1.20 level and continue to slide down to $1.07 today - 18 May.

From TA point of view, it is rather bearish. Looks like it may go down to $1.00 . Breaking down of $1.00 may head lower to 90 cents level.


Nav of 1.29.
Dividend of 4.5 cents.
Yield is about 4.25%.
PE is about 6.9x.
From FA wise, looks like value is surfacing!

Not a call to buy or sell.

Please do your own due diligence.




Yangzijiang Shipbuilding (Holdings) Ltd., an investment holding company, operates in the shipbuilding activities. The company operates through Shipbuilding, Investments, Trading, and Others segments. It produces a range of commercial vessels, such as containerships, dry bulk carriers, oil tankers, and liquefied natural gas (LNG) carriers. The company also engages in the production and processing of steel structures. In addition, it facilitates the sale and export of ships for the ship builder; trades in ship related equipment and shipbuilding related materials/supplies; provides microcredit to enterprises and individuals; invests in held-to-maturity financial assets; and supplies marine equipment and materials. Further, the company is involved in the ship demolition and vessel owning activities. It primarily serves ship owners in the United States, Canada, the United Kingdom, Germany, France, Greece, Norway, Argentina, Turkey, Bulgaria, Poland, Australia, Japan, South Korea, Singapore, India, Thailand, Bangladesh, Mainland China, Hong Kong, Taiwan, etc. The company was founded in 1956 and is headquartered in Jingjiang, China.

TianJin Zhong Xin

From TA point of view, it is on a nice uptrend mode chart patterns. The current price of $1.25 is staying well above its 20,50,100 & 200 days moving average, this is rather bullish.
Short term wise, looks like it may likely re-attempt the recent high of $1.29.Crossing over with ease + good volume that may propel to drive the price higher towards 1.35 then 1.40 with extension to 1.46.



 I think it might be good to lock in some profit !

 Not a call to buy or sell.


 Please do your own due diligence.

 NAV of RMB5.82

EPS RMB0.62

 Dividend of 2.1 us cents.

 Yield of about 2.24%


 Looking through their past financial nos from 2014 to 2018, we can notice that the Total Revenue is generally declining from S$1513m to S$1222m. Net Income has been rising from S$76m to S$108m.

 Even tough the Total Revenue is lower but Net Income has been rising could be due to lower costs and other gains that contributed to the rise of net income. You may want to look further into their financial report.

 Diluted EPS has also been rising from 6.8 cents to 9.8 cents.


 Total current assets of $904m is more than sufficient to cover its total liabilities of $447m.

 Cash flow from Operations is a little bit erratic. It fluctuates up and down. So is not very consistence.

 The latest 1Q 2018 result shows Net profit rises 31% from RMB133m to RMB171m.



 Tianjin Zhong Xin Pharmaceutical Group Corporation Limited, together with its subsidiaries, produces and sells traditional Chinese medicines, western medicines, and healthcare products primarily in the People’s Republic of China. The company is also involved in the manufacture and sale of biological products; wholesale and retail sale of medicines, biochemical pharmaceutical products, and daily use products; and operation of hospitals. In addition, it provides logistics, stocks, equipment installation, and medicine processing services. The company sells medicinal products under its own brand and other brands to wholesalers. Tianjin Zhong Xin Pharmaceutical Group Corporation Limited was founded in 1992 and is headquartered in Tianjin, the People’s Republic of China.

Parkway Life Reit

From TA point of view , it is on a down trend mode chart patterns! The current price of $2.69 is hovering below it's SMA lines , this is rather bearish.



Short term wise , I think it may likely retest the recent low of $2.68. Breaking down of this level , it may likely slide further down towards $2.63 level then $2.60 with extension to $2.52.

DPU is about 13.4 cents .
At $2.52 , yield is about 5.31%
I think at this price level we may see some accumulation activities..


ParkwayLife Reit - It owns the largest portfolio of strategically-located private hospitals in Singapore comprising Mount Elizabeth Hospital, Gleneagles Hospital and Parkway East Hospital. 

In addition, it has 45 assets located in Japan, including one pharmaceutical product distributing and manufacturing facility in Chiba Prefecture as well as 44 high quality nursing home and care facility properties in various prefectures of Japan. 

It also owns strata-titled units/lots at Gleneagles Intan Medical Centre Kuala Lumpur in Malaysia.


Looking through their financial nos from 2013 to 2017, we can notice that its Total Revenue is generally rising at a CAGR of 4.3% from 93693m in 2013 to 109,881m in 2017. This is quite consistently increasing for the past 4 years which is quite encouraging/positive.

Total Revenue - is the sum of cash inflows, increase in operating accounts such as receivables and occasionally, unrealized gains generated in the course of Company's Business activities.

Next, we can take a look at the Total Net Income level which has only generated an returns of only 0.81% (CAGR) from 98.279m in 2013 to 101.464m in 2017. The Net Income seems like not growing much. Investor may want to take note of this. 



The DPU has since a marginally increase from 0.107 in 2013 to 0.134 in 2017. An increase of 0.06% CAGR. The average yield for the past 4 years is about 0.122. Giving a yield of 4.38%.
This is generally below the 5to5.5 % yield expectation for investing in Reit counter.

NAV of $1.761, P/B is 1.61 times.

The Gearing % is about 40% which can be roughly calculated base on the Total Liabilites 705,881/ 1771,221 Total Assets . It is still within the guide line being set by MAS.. Generally, we would prefer gearing to be around 30-36%.


Ops cash flows seems quite pretty stable generating a Net cash from Ops is within 76 to 80m.



The current price of $2.69 is trading above it NAV of $1.761 and it is also trading above its fair value of about $2.14( using DDM to work out the fair value ) . I think it is trading at a premium price level and investor may want to take note of this.

Looking through the Historical chart patterns, we can use it as a reference .




Strong support level is around $2.20 level. The next support level would be $1.80.



Not a call to buy or sell.
Please do you own due diligence.

trade/invest base on your own decision. 



 Parkway Life Real Estate Investment Trust (“PLife REIT”) is one of Asia’s largest listed healthcare REITs by asset size. It invests in income-producing real estate and real estate related assets that are used primarily for healthcare and healthcare-related purposes (including but are not limited to, hospitals, healthcare facilities and real estate and/or real estate assets used in connection with healthcare research, education, and the manufacture or storage of drugs, medicine and other healthcare goods and devices). PLife REIT owns a well-diversified portfolio of 50 properties with a total portfolio size of approximately S$1.75 billion as at 31 December 2017.

Thursday, May 24, 2018

SingHaiyi

SingHaiyi rounds off FY2018 with 3.9% increase in net attributable profit as revenue soars to S$458.8 million

 Proposes a final cash dividend of 0.3 Singapore cent per share for FY2018, representing 40.0% of the year’s net attributable profit

 Strengthens balance sheet with cash and cash equivalents of S$194.0 million as at 31 March 2018 

 Well-positioned to capitalise on the recovering property sector in Singapore with the recent land acquisitions


NAV of 15.22 cents.
EPS of 1.097 cents
PE of 9.5x
Yield of 3.1%

Looks quite attractive.

Not a call to buy or sell.

Please do your own due diligence.


 SINGAPORE - 24 May 2018 - SGX-listed SingHaiyi Group Ltd. (“SingHaiyi” or the “Group”), a fastgrowing, diversified real estate company focused on property development, real estate investment and property management services, today announced higher revenue for the financial year ended 31 March 2018 (“FY2018”).


 Group Managing Director Mrs Celine Tang said, “The strong growth in the Group’s revenue during the year stands as a testament to the strong demand for our EC project, The Vales. Our focus on quality property developments over the years has helped us to establish a strong reputation in the market and won us the confidence of homebuyers who have bought homes from us. We will continue to place a premium on building quality and affordable developments that cater to the demands of the market.


 “Moreover, our continued efforts to maximise efficiency in our operations have also paid off as the Group recorded higher net profit during the year. This was despite the absence of a one-off disposal gain of S$30.5 million from the divestment of the Group’s 20.0% interest in TripleOne Somerset in FY2017, as well as a share of loss from equity accounted investees of S$1.3 million that was mainly due to the Group’s interest in ARA Harmony Fund III.”


  Cash on hand 


During the year, the Group strengthened its balance sheet with cash and cash equivalents of S$194.0 million as at 31 March 2018, up from S$51.7 million as at 31 March 2017, while gearing ratio stands at a healthy 30.9%, down from 54.1% a year ago.

To reward shareholders, the Board has proposed a final one-tier tax exempt dividend of 0.3 Singapore cent, which represents 40.0% of FY2018’s net attributable profit.


 Mrs Celine Tang said, “FY2018 has been a year of many achievements for SingHaiyi starting with our transfer from the Catalist to the Mainboard of the SGX-ST in May 2017, which is a validation of our hard work and successful growth strategy. We also ramped up our presence in Singapore with the expansion of our land bank which has put us among the top 4 developers in Singapore in terms of landbank inventory1 ,while our US properties are in the midst of transformations that we believe will lay the groundwork for their future success. Meanwhile, we also strengthened our geographic exposure and income stability via a strategic investment in Australia’s Cromwell Property Group. These initiatives place SingHaiyi in a strong strategic position to grow and we look forward to reaping the fruits of our labour in time to come.”


Looking ahead, the Group is well-positioned to capitalise on the recovering property sector in Singapore, given its recent land acquisitions. In the US, the Group will continue to focus on delivering its pipeline of development projects against the backdrop of a stable real estate market.
quote : http://infopub.sgx.com/FileOpen/SHG_Press_Release_FY2018.ashx?App=Announcement&FileID=507332


About SingHaiyi Group Ltd. 

SingHaiyi Group Ltd. (“SingHaiyi” or the “Group”) is a fast growing, diversified company focused on property development, investment and management services. With strategic support from its major shareholders, the Group is led by a board and management team, including esteemed businessmen Mr Gordon Tang and Mr Neil Bush, which has deep insights and strong connections that enable access to unique and rare investment opportunities. Apart from an established track record in residential property development, the Group also holds a diversified portfolio of income-generative assets in the commercial and retail sectors, with geographical reach into the US and widening exposure in Asia.

StarHub

StarHub :  Today has broken down the recent low of $2.08 but manage to bounce-off and close higher at $2.12 .



Looks like it it still not out of the wood yet and may likely retest $2.08 again.

Breaking down of $2.08 with high volume that may likely see it sliding further down  towards $2.00 then $1.91.



Current trend is down trend.

Do exercise with great care.

Not a call to buy or sell.

Please do your own due diligence.



 StarHub - looking through their financial nos, Net Income has been dropping from 370M of 2014 to 238m in 2017.

Dividend has been cut from 20 cents to 16 cents.








The latest 1Q 2018 result also shown a drop of 13% for the Net profit down from 72m to 63m.

Net profit is still dropping and not sure when will we be able to see a good improvement for the company to boost their Net income revenue!







Business Outlook:


➢ Revenue: Maintain service revenue to be 1% to 3% lower YoY

➢ Service EBITDA*: Expect service EBITDA margin to be between 27 - 29% after adoption of SFRS(I) 15

➢ CAPEX: Maintain cash capex to be about 11% of total revenue (excludes spectrum and building payments)

➢ Dividend: Declare an interim quarterly dividend of 4.0 cents per ordinary share for 1Q2018 Intend to pay a quarterly cash dividend of 4.0 cents per ordinary share for FY2018


*Service EBITDA refers to EBITDA less equipment margin (Sales of Equipment less Cost of Equipment)

Free Cash flow has also been drifting lower as reflected on the chart below: